Key facts
- It has raised $280K; the latest was Seed Round in Oct 2025.
- Notable investors include Elevate Ventures, Wellington Management, Boomerang Ventures, VisionTech Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for SinuSauna
- ·The full record, as it builds
Funding rounds
No funding rounds for SinuSauna are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SinuSauna
Developer of respiratory health technologies designed to help reduce the symptoms of infections. The company engages in developing products that address and treat upper respiratory ailments, leveraging historical infectious-disease research on the benefits of hyperthermic treatment of the nasopharynx to limit viral reproduction, enabling healthcare professionals to provide their patients with nasal wellness.
- Sector
- Healthcare
- HQ
- Indianapolis, IN, United States
- Founded
- 2021
- Employees
- 4
- Website
- sinusauna.com/
- Ownership
- Privately Held (backing)
SinuSauna doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SinuSauna shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SinuSauna in its N-PORT filings yet. We sweep new filings monthly.